US Equity
DBVT
— Dbv Technologies SADBV Technologies SA is a clinical-stage biopharmaceutical company developing Viaskin, a proprietary epicutaneous immunotherapy platform for the treatment of food allergies.
💰 Market cap: $823.12M📍 Batiment IRO, 107 Av. de la Republique, CHATILLON, AUVERGNE-RHONE-ALPES, 92320 FR🏷️ Pharmaceuticals💵 Previous close: $13.63🔢 9,756 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $13.63 |
| 2026-07-23 | $13.86 |
| 2026-07-22 | $13.63 |
| 2026-07-21 | $14.22 |
| 2026-07-20 | $14.57 |
| 2026-07-17 | $14.70 |
| 2026-07-16 | $14.86 |
| 2026-07-15 | $15.71 |
| 2026-07-14 | $15.92 |
| 2026-07-13 | $15.98 |
| 2026-07-10 | $16.49 |
| 2026-07-09 | $16.08 |
| 2026-07-08 | $16.75 |
| 2026-07-07 | $17.35 |
| 2026-07-06 | $15.61 |
| 2026-07-02 | $15.82 |
| 2026-07-01 | $15.73 |
| 2026-06-30 | $16.40 |
| 2026-06-29 | $16.00 |
| 2026-06-26 | $16.01 |
| 2026-06-25 | $16.02 |
| 2026-06-24 | $15.60 |
| 2026-06-23 | $16.11 |
| 2026-06-22 | $15.70 |
| 2026-06-18 | $15.53 |
| 2026-06-17 | $16.28 |
| 2026-06-16 | $16.75 |
| 2026-06-15 | $18.12 |
| 2026-06-12 | $17.41 |
| 2026-06-11 | $16.54 |
| 2026-06-10 | $16.04 |
| 2026-06-09 | $16.03 |
| 2026-06-08 | $16.00 |
| 2026-06-05 | $16.59 |
| 2026-06-04 | $17.58 |
| 2026-06-03 | $17.70 |
| 2026-06-02 | $18.23 |
| 2026-06-01 | $18.80 |
| 2026-05-29 | $19.10 |
| 2026-05-28 | $18.99 |
| 2026-05-27 | $18.50 |
| 2026-05-26 | $18.16 |
| 2026-05-22 | $18.18 |
| 2026-05-21 | $18.57 |
| 2026-05-20 | $18.54 |
| 2026-05-19 | $18.51 |
| 2026-05-18 | $18.75 |
| 2026-05-15 | $19.65 |
| 2026-05-14 | $19.84 |
| 2026-05-13 | $19.60 |
| 2026-05-12 | $20.00 |
| 2026-05-11 | $20.36 |
| 2026-05-08 | $19.73 |
| 2026-05-07 | $19.99 |
| 2026-05-06 | $20.10 |
| 2026-05-05 | $19.49 |
| 2026-05-04 | $19.47 |
| 2026-05-01 | $19.87 |
| 2026-04-30 | $21.00 |
| 2026-04-29 | $20.30 |
| 2026-04-28 | $20.80 |